The up-regulation of ERBB3 in ARID2-deficient cells indicates that the absence of ARID2 promotes tumor progression through a critical pathway, underscoring its importance in maintaining cellular homeostasis and preventing tumorigenesis. This evidence concerns the gene ARID2 and neoplasm.